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Abstract
Background: Endometriosis is an enigmatic disease. Gene expression profiling of endometriosis
has been used in several studies, but few studies went further to classify subtypes of endometriosis
based on expression patterns and to identify possible pathways involved in endometriosis. Some of
the observed pathways are more inconsistent between the studies, and these candidate pathways
presumably only represent a fraction of the pathways involved in endometriosis.
Methods: We applied a standardised microarray preprocessing and gene set enrichment analysis
to six independent studies, and demonstrated increased concordance between these gene datasets.
Results:  We find 16 up-regulated and 19 down-regulated pathways common in ovarian
endometriosis data sets, 22 up-regulated and one down-regulated pathway common in peritoneal
endometriosis data sets. Among them, 12 up-regulated and 1 down-regulated were found
consistent between ovarian and peritoneal endometriosis. The main canonical pathways identified
are related to immunological and inflammatory disease. Early secretory phase has the most over-
represented pathways in the three uterine cycle phases. There are no overlapping significant
pathways between the dataset from human endometrial endothelial cells and the datasets from
ovarian endometriosis which used whole tissues.
Conclusion: The study of complex diseases through pathway analysis is able to highlight genes
weakly connected to the phenotype which may be difficult to detect by using classical univariate
statistics. By standardised microarray preprocessing and GSEA, we have increased the
concordance in identifying many biological mechanisms involved in endometriosis. The identified
gene pathways will shed light on the understanding of endometriosis and promote the development
of novel therapies.
Background
Endometriosis is defined as the presence of endometrium-
like tissue in sites outside the uterine cavity and occurs in
6-10% of women in the general population [1]. The main
clinical features are chronic pelvic pain, pain during inter-
course, and infertility [2]. As cellular and molecular mech-
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anisms involved in endometriosis are still uncovered, the
classification of this disease evolved from a local disorder
to a complex, chronic systemic disease [3]. Despite exten-
sive researches, the etiology of endometriosis remains
obscure. Gene expression profiling has been used in sev-
eral studies of endometriosis, in which from a few to hun-
dreds differentially expressed genes were identified [4-17].
For previously identified genes, their roles in the patho-
genesis of endometriosis are further discussed. But it is
hard to interpret individual genes on a list with many sig-
nificant genes.
A common challenge in the analysis of genome wide
expression no longer lies in obtaining gene expression
profiles, but rather in interpreting the results to gain
insights into biological mechanisms [18]. Pathway analy-
sis of microarray data evaluates gene expression profiles of
a priori defined biological pathways in association with a
phenotype of interest. Recently gene expression patterns
were further used in the classification of subtypes of
endometriosis as well as in the identification of the path-
ways involved in endometriosis [4,13-16]. So far the
observed pathways were discordant between the studies
that suggest that these previously identified pathways only
represent a fraction of the pathways involved in endome-
triosis.
Currently the most well-known and widely used approach
to gene set analysis, the Gene Set Enrichment Analysis
(GSEA) method was introduced by Mootha et al. [19],
which was used to identify pre-defined gene sets which
exhibited significant differences in expression between
samples from normal and patients. The methodology was
subsequently refined by Subramanian et al. [18]. The
algorithms calculate the statistical significance of the
expression changes across groups or pathways rather than
individual gene, thus allowing identification of groups or
pathways most strongly affected by the observed expres-
sion changes. The analysis based on a group of relevant
genes instead of on an individual gene increases the like-
lihood for investigators to identify the critical functional
processes under the biological phenomena under study.
GSEA is likely to be more powerful than conventional sin-
gle-gene methods in the study of complex diseases in
which many genes make subtle contributions [20].
In a single data set the GSEA will generally not result in
significant findings beyond major pathways. Here we will
use standardised microarray preprocessing and GSEA with
comprehensive expression profiles in an attempt to find
greater data convergence and provide a systematic insight
into the pathways altered during endometriosis pathogen-
esis.
Methods
Datasets
We searched GEO http://www.ncbi.nlm.nih.gov/geo/,
and ArrayExpress http://www.ebi.ac.uk/arrayexpress/ for
the gene expression profiling studies related to endometri-
osis disease. Data were included in our re-analysis if they
met the following conditions: 1) the data is in genome-
wide; 2) comparison was conducted between endometri-
osis patients and controls; 3) complete microarray raw or
normalized data are available.
Finally six public gene expression data sets were involved
in our study, which assessed endometriosis transcripts on
a genome-wide basis. In data set GSE7307, total 677 sam-
ples from more than 90 distinct tissue types were proc-
essed, but only the profiles related to endometriosis and
eutopic endometrium were considered here. The data gen-
erated from human endometrial endothelial cells by Sha
et al. [4] were also included in our combined re-analysis
to compare with the whole endometriosis tissues data
sets. The related information about these datasets, such as
the microarray platform, sample type, sample size, is
listed in Table 1.
Table 1: Characteristics of datasets included in the studies.
First Author
or Contributor
Chip GEO Accession Experimental design Classification Probes Number of samples
Disease Normal
Sha [4] U133 PLUS 2.0 GSE7846 unpaired, HEECS ovarian 54K 5 5
Burney [14] U133 PLUS 2.0 GSE6364 unpaired, tissues Ovarian, peritoneal,
rectovaginal
54K 21 16
Eyster [15] CodeLink GSE5108 paired, tissues Ovarian, peritoneal 55K 6/5 6/5
Hever [16] U133 PLUS 2.0 GSE7305 paired, tissues ovarian 54K 10 10
Roth U133 PLUS 2.0 GSE7307 unpaired, tissues ovarian 54K 18 23
Hull [17] U133A GSE11691 paired, tissues peritoneal 22K 9 9
paried: compare eutopic endometrium to ectopic endometrium from the same patients with entire endometrial tissue.
unparied: compare eutopic endometrium from women with endometriosis to eutopic endometrium from women without endometriosis.
HEECS: human endometrial endothelial cells samples.Reproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
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Data Preprocessing
Data preprocessing was performed using software pack-
ages developed in version 2.4.0 of Bioconductor [21] and
R version 2.9.0 [22]. Each Affymetrix dataset was back-
ground adjusted, normalized and log2 probe-set intensi-
ties calculated using the Robust Multichip Averaging
(RMA) algorithm in affy package [23,24], and the Code-
link arrays normalizations performed in GSE5108 were
retained. Genes which cannot be mapped to any KEGG
pathway identified were excluded from the further analy-
sis. The interquartile range (IQR) was used as a measure of
variability. From the resulting distribution of IQR values
for all genes we set a cut-off so as to exclude values under
0.5. When multiple probe sets target one gene, the probe
set with largest variability was kept. Pathway analysis was
performed separately in each data set.
Gene set enrichment analysis of pathways
GSEA implemented in the Category package (version
2.10.1 [25]). The goal of GSEA is to determine whether
the members of a gene set S  randomly distributed
throughout the entire reference gene list L or are primarily
found at the top or bottom. One of the advantages of
GSEA is the relative robustness to noise and outliers in the
data. The gene sets represented by less than 10 genes were
excluded. The t-statistic mean of the genes was computed
in each pathway. Using a permutation test with 1000
times, the significantly changed pathways were identified
with p-value ≤ 0.05.
Results
For the studies which used multiple locations (ovarian
and peritoneal) or uterine cycle phases (proliferative to
secretory) of endometriosis, each type or phase was
treated as a separate data set. These six studies provided 9
case-control data sets including 74 endometriosis cases
and 74 controls. Common GSEA method was applied to
the 9 datasets. For individual analysis, we obtained the
significant pathways and the genes included [See Addi-
tional file 1, 2, 3 and 4]. The analysis results were summa-
rised in table 2. We postulated that the pathways and
genes that appear consistently as different expressed in
multiple studies are more likely to be important in
endometriosis. To look for such convergence we com-
pared the GSEA results.
Common significant pathways in ovarian endometriosis
Endometriosis is most commonly localized in the ovaries.
We first compared the ovarian endometriosis data sets for
their convergence and reproducibility. The results for the
ovarian endometriosis data sets were presented in Table 3.
Based on the permutation p-values, the GSEA reported 24
& 31 (Eyster data set), 56 & 59 (Hever data set), and 36 &
44 (Roth data set) up- and down- regulated pathways. The
overlaps among them are presented in Figure 1, with 16
up-regulated and 19 down-regulated pathway detected in
common. Among the up-regulated list, the main canoni-
cal pathways affected are related to immunological and
inflammatory diseases including Asthma, Autoimmune
thyroid disease, Systemic lupus erythematosus, Allograft
rejection, Graft-versus-host disease and Type I diabetes
mellitus. Cytokine-cytokine receptor interaction and Cell
adhesion molecules (CAMs) belongs to signaling mole-
cules and interaction. PPAR signaling pathway is part of
endocrine system. The most down-regulated pathways are
metabolism and repair related pathways. And we
extracted the collective genes in each pathway from the 3
data sets [See Additional file 5].
Common significant pathways in peritoneal endometriosis
We also analyzed the data sets from peritoneal endometri-
osis which is another important endometriosis type. 23
Table 2: Summary of each data set used in the re-analysis and the number of differentially expressed pathways.
Studies Number of 
patients
Number of 
controls
Number of genes 
after preprocessing
Number of 
pathways have 
genes ≥ 10
Up-regulated 
pathways
Down-regulated 
pathways
Ovarian Data Sets
Eyster 6 6 3105 171 24 31
Hever 10 10 1930 139 56 59
Roth 18 23 2575 154 36 44
Peritoneal Data Sets
Eyster 5 5 3084 171 57 11
Hull 9 9 1255 113 29 7
Uterine cycle Data Sets
Burney_Pro 6 5 1900 138 4 3
Burney_ES 6 3 1471 122 12 21
Burney_MS 9 8 952 93 0 22
Human endometrial endothelial cells Data Set
Sha 5 5 2324 153 44 1
Pro, Proliferative; ES, early secretory; MS, midsecretory ProliferativeReproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
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pathways were commonly significantly regulated in the
two peritoneal endometriosis data sets, summarised in
table 4 and Figure 2. Of these 23 pathways, 12 up- and
one down- regulation pathways were also identified from
the three ovarian endometriosis data sets. The significan-
ces of four pathways (Drug metabolism - cytochrome
P450, Metabolism of xenobiotics by cytochrome P450,
Olfactory transduction, Toll-like receptor signaling path-
way) were found from the data of Eyster et al. [15], but not
in the data of Hull et al. [17]. Collective genes in each
pathway were extracted [See Additional file 6].
Differential pathways between the timing of the uterine 
cycle
Burney et al. conducted global gene expression analysis of
endometrium from women with and without moderate/
severe stage endometriosis and compared the gene expres-
sion signatures across various phases of the menstrual
cycle [14]. Specimens were classified as proliferative (PE,
d 8-14), early secretory (ESE, d 15-18), midsecretory
(MSE, d 19-23). They did not examine later than Day 23
in the menstrual cycle. Each phase had endometriosis
more than one type. We re-analyzed their microarray CEL
files and each phase was treated as a separate data set. In
proliferative phase, 4 pathways were up-regulated and 3
pathways were down-regulated. Early secretory phase had
the most over-represented pathways, 12 were up-regu-
lated and 21 were down-regulated. There is no significant
pathway up-regulated at p ≤ 0.05 in midsecretory phase
while 22 down-regulated pathways were identified [See
Additional file 3]. The overlap of pathways among these
phases is very low (Figure 3).
Differential expression in human endometrial endothelial 
cells
Sha et al. selected the eutopic endothelial compartment as
the subject for exploring the differential expression profile
between endometriosis patients and normal controls [4].
Our re-analysis revealed 44 up-regulated and 1 down-reg-
ulated pathways in the dataset [See Additional file 4].
There is no overlap compared with the common list from
ovarian endometriosis data sets using the whole tissue as
sample.
Discussion
Endometriosis is an enigmatic disease. No existing single
theory can explain all cases of endometriosis. The
genome-wide microarrays are very powerful because they
allow the identification of gene families or pathways that
change in concert in a disease state comprehensively. Bio-
logically relevant inference should therefore be reproduc-
ible across laboratories. For single gene analysis, different
statistical methods and different datasets examining the
same biological condition may lead to significant discrep-
ancies [26]. Pathways analysis applied to different data-
sets yields interesting common results, diminishing the
large discrepancies observed in direct comparisons of lists
of differentially expressed genes obtained from different
datasets. Therefore, the study of complex diseases through
pathway analysis is able to highlight genes weakly con-
nected to the phenotype which may be difficult to detect
by using classical univariate statistics.
We have performed gene set enrichment analysis of six
independent publicly available gene expression data sets
to understand in depth the common biological mecha-
nisms involved in endometriosis. Our study compared
the gene expression between lesion locations (ovarian vs.
peritoneal), phases of the uterine cycle (proliferative to
midsecretory) and cell types (endometrial endothelial
cells vs. whole tissue), as well as overall eutopic versus
ectopic endometrium. The transcriptomes of eutopic
endometrium and ectopic endometrial lesions suggest
that ovarian endometriosis and peritoneal disease are dif-
ferent disorders [13]. Our findings suggest that most of
the pathways impacted the ovarian and peritoneal
endometriosis are consistent. Many of differentially
expressed pathways found in this study have already been
reported to be involved in endometriosis pathogenesis.
Here, this discussion presents several of the differentially
Significant pathways identified and overlap between the 3  ovarian endometriosis data sets Figure 1
Significant pathways identified and overlap between 
the 3 ovarian endometriosis data sets. For each data 
set, GSEA implanted to generate p-values for each pathway 
and using a permutation test with 1000 times, obtained the 
significant pathways with p-value cut-off of ≤ 0.05. (a) GSEA 
detected 24 (Eyster data set), 56 (Hever data set) and 36 
(Roth data set) up-regulated pathways and 16 are common. 
(b) GSEA detected 31 (Eyster data set), 59 (Hever data set) 
and 44(Roth data set) down-regulated pathways and 19 are 
common.
Eyster Hever
Roth
6
26
11
2
3
3
16
Eyster Hever
Roth
4
21
18
8
3
1
19
(a)
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expressed pathways and hypotheses regarding the role of
these pathways in endometriosis.
Most significant of the common up-regulated pathways
are involved in immune system and immune disorders. It
has been widely documented that endometriosis, as an
inflammatory disease, induces an immune response, lead-
ing to both cellular and humoral immune changes
[27,28]. The association between endometriosis and
immune disorders were literature supported [29]. Also
some studies concluded that women with endometriosis
do not have a higher risk of having asthma, systemic lupus
erythematosus and Sjögren's syndrome than other sub-
jects [30,31]. Our GSEA results showed that expression of
Asthma, Graft-versus-host disease, Autoimmune thyroid
disease, Allograft rejection, Systemic lupus erythematosus
and Type I diabetes mellitus pathways are the significantly
imbalanced between endometriosis and eutopic
endometrium. We found that human leukocyte antigen
(HLA) genes are critical genes in these pathways. HLA are
key components of the major histocompatibility complex
(MHC), which is involved in immune cell signalling proc-
esses such as T-cell activation. People with certain HLA
antigens are more likely to develop certain autoimmune
diseases, such as Type I Diabetes, Ankylosing spondylitis,
Celiac Disease, Systemic Lupus Erythematosus, Myasthe-
nia Gravis and Sjögren's syndrome et al [32].
Cytokine-cytokine receptor interaction and Cell adhesion
molecules (CAMs) included in GSEA were up-regulated in
endometriosis. Cell adhesion molecules are (glyco) pro-
teins expressed on the cell surface and play a critical role
Table 3: Common pathway categories identified by GSEA of the 3 ovarian endometriosis datasets
Pathway name Classification Genes
Up-regulation
PPAR signaling pathway Endocrine System 26
Cytokine-cytokine receptor interaction Signaling Molecules and Interaction 84
Cell adhesion molecules (CAMs) Signaling Molecules and Interaction 68
Complement and coagulation cascades Immune System 32
Toll-like receptor signaling pathway Immune System 37
Hematopoietic cell lineage Immune System 36
Asthma Immune Disorders 12
Autoimmune thyroid disease Immune Disorders 16
Systemic lupus erythematosus Immune Disorders 29
Allograft rejection Immune Disorders 16
Graft-versus-host disease Immune Disorders 17
Arachidonic acid metabolism Lipid Metabolism 19
Metabolism of xenobiotics by cytochrome P450 Xenobiotics Biodegradation and Metabolism 19
Drug metabolism - cytochrome P450 Xenobiotics Biodegradation and Metabolism 20
Type I diabetes mellitus Metabolic Disorders 19
Olfactory transduction Sensory System 4
Down-regulation
Fatty acid metabolism Lipid Metabolism 21
Androgen and estrogen metabolism Lipid Metabolism 5
Sphingolipid metabolism Lipid Metabolism 18
Oxidative phosphorylation Energy Metabolism 44
Citrate cycle (TCA cycle) Carbohydrate Metabolism 13
Butanoate metabolism Carbohydrate Metabolism 12
Pyrimidine metabolism Nucleotide Metabolism 36
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis Glycan Biosynthesis and Metabolism 10
Lysine degradation Amino Acid Metabolism 19
Folate biosynthesis Metabolism of Cofactors and Vitamins 10
DNA polymerase Replication and Repair 22
Base excision repair Replication and Repair 16
Nucleotide excision repair Replication and Repair 19
Mismatch repair Replication and Repair 13
Homologous recombination Replication and Repair 10
Cell cycle Cell Growth and Death 57
Thyroid cancer Cancers 15
Proteasome Folding, Sorting and Degradation 13
Ubiquitin mediated proteolysis Folding, Sorting and Degradation 50
Genes: Number of common genes included in the pathway.Reproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
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in a wide array of biologic processes that include hemos-
tasis, the immune response, inflammation, embryogene-
sis, and development of neuronal tissue. Clinical
observations and in vitro experiments imply that
endometriotic cells are invasive and able to metastasize.
Analogous to tumour metastasis, it is likely that cell adhe-
sion molecules are central for the invasion and metastasis
of endometriotic cells. The expression of some integrins is
aberrant in endometriotic lesions compared to eutopic
endometrium [33]. Cytokines are key mediators of inter-
cellular communication within the immune system. Sev-
eral cytokines including interleukin (IL)-1, 6, 8, 10, tumor
necrosis factor (TNF)-α, and vascular endothelial growth
factor (VEGF) were reported to be increased in the perito-
neal fluid (PF) of women with endometriosis [34-41].
Peroxisome proliferator-activated receptors (PPARs) sign-
aling pathway is up-regulated according to GSEA. PPAR
are nuclear hormone receptors that are activated by fatty
acids and their derivatives. PPAR-γ is present in human
ovarian cells. Activation of PPAR-γ enhances steroidogen-
esis via activation of StAR protein and leads to the activa-
tion of insulin-signaling pathways [42].
The expression patterns of ER (estrogen receptors) and PR
(progesterone receptors) in endometriotic lesions are dif-
ferent from those in the eutopic endometrium. Endome-
Significant pathways identified and overlap between the 2  peritoneal endometriosis data sets Figure 2
Significant pathways identified and overlap between 
the 2 peritoneal endometriosis data sets. For each data 
set, GSEA implanted to generate p-values for each pathway 
and using a permutation test with 1000 times, obtained the 
significant pathways with p-value cut-off of ≤ 0.05. (a) GSEA 
detected 57 (Eyster data set) and 29 (Hull data set) up-regu-
lated pathways and 22 are common. (b) GSEA detected 11 
(Eyster data set) and 7 (Hull data set) down-regulated path-
ways and 1 is common.
Eyster Hull
7 35 22
Eyster Hull
6 10 1
(a)
(b)
Table 4: Common pathway categories identified by GSEA of the 2 peritoneal endometriosis datasets
Pathway name Classification Genes
Up-regulation
Cell Communication Cell Communication 42
Focal adhesion Cell Communication 91
Regulation of actin cytoskeleton Cell Motility 61
PPAR signaling pathway Endocrine System 19
Calcium signaling pathway Signal Transduction 41
VEGF signaling pathway Signal Transduction 25
Cytokine-cytokine receptor interaction Signaling Molecules and Interaction 58
Neuroactive ligand-receptor interactio Signaling Molecules and Interaction 20
ECM-receptor interaction Signaling Molecules and Interaction 46
Cell adhesion molecules (CAMs) Signaling Molecules and Interaction 49
Complement and coagulation cascades Immune System 29
Hematopoietic cell lineage Immune System 29
Leukocyte transendothelial migration Immune System 44
Asthma Immune Disorders 7
Autoimmune thyroid disease Immune Disorders 12
Systemic lupus erythematosus Immune Disorders 20
Allograft rejection Immune Disorders 12
Graft-versus-host disease Immune Disorders 15
Arachidonic acid metabolism Lipid Metabolism 16
Type I diabetes mellitus Metabolic Disorders 15
Pancreatic cancer Cancers 24
Glioma Cancers 21
Down-regulation
Sphingolipid metabolism Lipid Metabolism 13
Genes: Number of common genes included in the pathway.Reproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
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triosis is an estrogen-dependent disease [43]. Studies of
hormone-ligand binding assays and enzyme immu-
noassays showed a consistent reduction in the content of
ER and PR in endometriotic implants [44-47]. Androgen
and estrogen metabolism pathway appeared in most of
our re-analysis results. Oxidative phosphorylation path-
way possibly affect oocyte quality, fertilization rate, and
further embryo development [48], is down-regulated in
our analysis.
Burney et al. studied proliferative, early secretory and mid-
secretory eutopic endometrium (up to Day 23), from
women with endometriosis and controls. They found that
endometrial gene expression differed most, between these
groups, in the early secretory phase (Days 15-18). They
found far fewer differences in the mid-secretory phase
where no transcripts were found to be up- or down-regu-
lated 4-fold. The result is consistent with the findings of
other studies [12,49,50]. Corresponding to their result,
there is no significant up-regulated pathway in mid-secre-
tory phase by our GSEA. The molecular phenotype of mid-
secretory, eutopic endometrium from women with
endometriosis and from controls appears to be very simi-
lar [50]. Current efforts to develop minimally invasive
diagnostic tests for the presence of endometriosis and also
tests to distinguish minimal/mild and moderate/severe
disease, by sampling the endometrium, should be focused
on the early secretory phase of the menstrual cycle [50].
We hypothesize that all cell types in the endometriotic
lesion contribute to the pathology of the disease. Matsu-
zaki et al. compared global gene expression in eutopic
endometrium, from controls and patients with deep
endometriosis, at various time points throughout the
menstrual cycle. They found no genes were up- or down-
regulated in all phases of the cycle, in either tissue com-
partments [12]. None of the genes from their study that
had been identified as differentially expressed in either
the stromal or epithelial compartments was shown to be
differentially expressed. This may be due to the relative
contribution that the epithelial and stromal transcrip-
tomes make to whole tissue gene expression. Our GSEA
result showed that the significant pathways from the
human endometrial endothelial cells had low overlap
with the list from ovarian endometriosis data sets used
whole tissue.
Conclusion
The pathogenesis of endometriosis is likely multifactorial.
A deeper understanding of the mechanisms of these dis-
eases can be reached by focusing on deregulation of gene
sets or pathways rather than on individual genes. By
standardised microarray preprocessing and GSEA, we
have increased the concordance to identify many biologi-
cal mechanisms are involved in endometriosis which are
novel in terms of their connection to endometriosis (as
mined from the existing literature). More studies about
the specific role and interactions of the genes included in
related pathways are needed to improve the understand-
ing of endometriosis.
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Significant pathways identified and overlap between the  phases of uterine cycle Figure 3
Significant pathways identified and overlap between 
the phases of uterine cycle. For each phase, GSEA 
implanted to generate p-values for each pathway and using a 
permutation test with 1000 times, obtained the significant 
pathways with p-value cut-off of ≤ 0.05. (a) GSEA detected 4 
(Proliferative phase), 12 (Early secretory phase) and 0 (Mid 
secretory phase) up-regulated pathways and no overlap. (a) 
GSEA detected 3 (Proliferative phase), 21 (Early secretory 
phase) and 22 (Mid secretory phase) down-regulated path-
ways and the overlap is very low.
Proliferative Early secretory
Midsecretory
0
12
0
4
0
0
0
Proliferative Early secretory
Midsecretory
18
17
3
1
1
1
0
(a)
(b)Reproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
Page 8 of 9
(page number not for citation purposes)
Acknowledgements
This work was supported by the National Natural Science Foundation of 
China (grant numbers 30871782 and 30671492), National High Technology 
Research and Development Program of China (863 Program) (grant 
number 2006AA10Z1E3).
References
1. Eskenazi B, Warner ML: Epidemiology of endometriosis.  Obstet
Gynecol Clin North Am 1997, 24(2):235-258.
2. Giudice LC, Kao LC: Endometriosis.  Lancet 2004,
364(9447):1789-1799.
3. Bulun SE: Endometriosis.  N Engl J Med 2009, 360(3):268-279.
4. Sha G, Wu D, Zhang L, Chen X, Lei M, Sun H, Lin S, Lang J: Differ-
entially expressed genes in human endometrial endothelial
cells derived from eutopic endometrium of patients with
endometriosis compared with those from patients without
endometriosis.  Hum Reprod 2007, 22(12):3159-3169.
5. Kato N, Sasou S, Motoyama T: Expression of hepatocyte nuclear
factor-1beta (HNF-1beta) in clear cell tumors and endome-
triosis of the ovary.  Mod Pathol 2006, 19(1):83-89.
6. Eyster KM, Boles AL, Brannian JD, Hansen KA: DNA microarray
analysis of gene expression markers of endometriosis.  Fertil
Steril 2002, 77(1):38-42.
7. Lebovic DI, Baldocchi RA, Mueller MD, Taylor RN: Altered expres-
sion of a cell-cycle suppressor gene, Tob-1, in endometriotic
cells by cDNA array analyses.  Fertil Steril 2002, 78(4):849-854.
8. Arimoto T, Katagiri T, Oda K, Tsunoda T, Yasugi T, Osuga Y,
Yoshikawa H, Nishii O, Yano T, Taketani Y, Nakamura Y: Genome-
wide cDNA microarray analysis of gene-expression profiles
involved in ovarian endometriosis.  Int J Oncol 2003,
22(3):551-560.
9. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K,
Lessey BA, Giudice LC: Expression profiling of endometrium
from women with endometriosis reveals candidate genes for
disease-based implantation failure and infertility.  Endocrinol-
ogy 2003, 144(7):2870-2881.
10. Fan Y, Chen BL, Ma XD, Su MQ: Detection of expression of
endometriosis-related cytokine and their receptor genes by
cDNA microarray technique.  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
2005, 21(4):489-492.
11. Matsuzaki S, Canis M, Pouly JL, Dechelotte P, Okamura K, Mage G:
The macrophage stimulating protein/RON system: a poten-
tial novel target for prevention and treatment of endometri-
osis.  Mol Hum Reprod 2005, 11(5):345-349.
12. Matsuzaki S, Canis M, Vaurs-Barriere C, Boespflug-Tanguy O, Das-
tugue B, Mage G: DNA microarray analysis of gene expression
in eutopic endometrium from patients with deep endome-
triosis using laser capture microdissection.  Fertil Steril 2005,
84(Suppl 2):1180-1190.
13. Wu Y, Kajdacsy-Balla A, Strawn E, Basir Z, Halverson G, Jailwala P,
Wang Y, Wang X, Ghosh S, Guo SW: Transcriptional character-
izations of differences between eutopic and ectopic
endometrium.  Endocrinology 2006, 147(1):232-246.
14. Burney R, Talbi S, Hamilton A, Vo K, Nyegaard M, Nezhat C, Lessey
B, Giudice L: Gene Expression Analysis of Endometrium
Reveals Progesterone Resistance and Candidate Susceptibil-
ity Genes in Women with Endometriosis.  Endocrinology 2007,
148(8):3814.
15. Eyster KM, Klinkova O, Kennedy V, Hansen KA: Whole genome
deoxyribonucleic acid microarray analysis of gene expres-
sion in ectopic versus eutopic endometrium.  Fertil Steril 2007,
88(6):1505-1533.
16. Hever A, Roth R, Hevezi P, Marin M, Acosta J, Acosta H, Rojas J, Her-
rera R, Grigoriadis D, White E: Human endometriosis is associ-
ated with plasma cells and overexpression of B lymphocyte
stimulator.  Proceedings of the National Academy of Sciences 2007,
104(30):12451.
17. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC,
Smith SK, Tavare S, Print CG, Charnock-Jones DS: Endometrial-
peritoneal interactions during endometriotic lesion estab-
lishment.  Am J Pathol 2008, 173(3):700-715.
18. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gil-
lette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP:
Gene set enrichment analysis: a knowledge-based approach
for interpreting genome-wide expression profiles.  Proc Natl
Acad Sci USA 2005, 102(43):15545-15550.
19. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar
J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly
MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B,
Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-
responsive genes involved in oxidative phosphorylation are
coordinately downregulated in human diabetes.  Nat Genet
2003, 34(3):267-273.
20. Jing Shi, Walker MG: Gene set enrichment analysis (GSEA) for
interpreting gene expression profiles.  Current Bioinformatics
2007, 2(2):133-137.
21. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S,
Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W,
Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G,
Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open
software development for computational biology and bioin-
formatics.  Genome Biol 2004, 5(10):R80.
22. R Development Core Team: R: A language and environment for
statistical computing.  2009 [http://www.R-project.org/]. R Foun-
dation for Statistical Computing, Vienna, Austria ISBN 3-900051-07-0
Additional file 2
Table 6: Pathway analysis of peritoneal endometriosis data sets. The 
data provided represent the list of significant pathways identified by GSEA 
in the 2 peritoneal endometriosis data sets.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-7-94-S2.xls]
Additional file 3
Table 7: Pathway analysis between the timing of the uterine cycle. The 
data provided represent the list of significant pathways identified by GSEA 
between the timing of the uterine cycle.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-7-94-S3.xls]
Additional file 4
Table 8: Pathway analysis in the specific phenotype of HEECs from 
endometriosis. The data provided represent the list of significant path-
ways identified by GSEA involved in the specific phenotype of HEECs from 
endometriosis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-7-94-S4.xls]
Additional file 5
Table 9: Common significant pathways in ovarian endometriosis data 
sets. The data provided represent the list of common significant pathways 
from GSEA of the 3 ovarian endometriosis datasets.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-7-94-S5.xls]
Additional file 6
Table 10: Common significant pathways in peritoneal endometriosis 
data sets. The data provided represent the list of common significant path-
ways from GSEA of the 2 peritoneal endometriosis datasets.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-7-94-S6.xls]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2009, 7:94 http://www.rbej.com/content/7/1/94
Page 9 of 9
(page number not for citation purposes)
23. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ,
Scherf U, Speed TP: Exploration, normalization, and summa-
ries of high density oligonucleotide array probe level data.
Biostatistics 2003, 4(2):249-264.
24. Gautier L, Cope L, Bolstad BM, Irizarry RA: affy--analysis of
Affymetrix GeneChip data at the probe level.  Bioinformatics
2004, 20(3):307-315.
25. Using Categories to Model Genomic Data  2009 [http://
www.bioconductor.org/packages/2.4/bioc/vignettes/Category/inst/
doc/Category.pdf].
26. Manoli T, Gretz N, Grone H-J, Kenzelmann M, Eils R, Brors B: Group
testing for pathway analysis improves comparability of dif-
ferent microarray datasets.  Bioinformatics 2006,
22(20):2500-2506.
27. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P: High rates
of autoimmune and endocrine disorders, fibromyalgia,
chronic fatigue syndrome and atopic diseases among women
with endometriosis: a survey analysis.  Hum Reprod 2002,
17(10):2715-2724.
28. Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endome-
triosis.  Fertility and Sterility 2001, 75(1):1-10.
29. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS:
Macrophage expression in endometrium of women with and
without endometriosis.  Hum Reprod 2009, 24(2):325-332.
30. Ferrero S, Petrera P, Colombo BM, Navaratnarajah R, Parisi M,
Anserini P, Remorgida V, Ragni N: Asthma in women with
endometriosis.  Hum Reprod 2005, 20(12):3514-3517.
31. Matorras R, Ocerin I, Unamuno M, Nieto A, Peiro E, Burgos J,
Exposito A: Prevalence of endometriosis in women with sys-
temic lupus erythematosus and Sjogren's syndrome.  Lupus
2007, 16(9):736-740.
32. de Bakker PIW, McVean G, Sabeti PC, Miretti MM, Green T, Marchini
J, Ke XY, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richard-
son A, Walsh EC, Gao XJ, Galver L, Hart J, Hafler DA, Pericak-Vance
M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, Vyse TJ, Beck S, Mur-
ray SS, Carrington M, Gregory S, Deloukas P, Rioux JD: A high-res-
olution HLA and SNP haplotype map for disease association
studies in the extended human MHC.  Nature Genet 2006,
38(10):1166-1172.
33. Starzinski-Powitz A, Handrow-Metzmacher H, Kotzian S: The puta-
tive role of cell adhesion molecules in endometriosis: can we
learn from tumour metastasis?  Molecular Medicine Today 1999,
5(7):304-309.
34. Wu MY, Ho HN, Chen SU, Chao KH, Chen CD, Yang YS: Increase
in the production of interleukin-6, interleukin-10, and inter-
leukin-12 by lipopolysaccharide-stimulated peritoneal mac-
rophages from women with endometriosis.  Am J Reprod
Immunol 1999, 41(1):106-111.
35. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Yang YS: Perito-
neal interleukin-10 increases with decrease in activated
CD4+ T lymphocytes in women with endometriosis.  Hum
Reprod 1997, 12(11):2528-2533.
36. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Chen HF, Yang YS:
Decrease in interferon gamma production and impairment
of T-lymphocyte proliferation in peritoneal fluid of women
with endometriosis.  Am J Obstet Gynecol 1996, 175(5):1236-1241.
37. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR: IL-1 beta,
TNF-alpha, and IL-2 in peritoneal fluid and macrophage-con-
ditioned media of women with endometriosis.  Am J Reprod
Immunol 1995, 34(6):381-385.
38. Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M,
Terakawa N: Increased interleukin-6 levels in peritoneal fluid
of infertile patients with active endometriosis.  Am J Obstet
Gynecol 1997, 176(3):593-597.
39. Punnonen J, Teisala K, Ranta H, Bennett B, Punnonen R: Increased
levels of interleukin-6 and interleukin-10 in the peritoneal
fluid of patients with endometriosis.  Am J Obstet Gynecol 1996,
174(5):1522-1526.
40. Hornung D, Bentzien F, Wallwiener D, Kiesel L, Taylor RN: Chem-
okine bioactivity of RANTES in endometriotic and normal
endometrial stromal cells and peritoneal fluid.  Mol Hum
Reprod 2001, 7(2):163-168.
41. Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A,
Johnson MC: Nuclear Factor kappa B (NF{kappa}B) pathway
and Interleukin-6 (IL-6) are affected in eutopic endometrium
of women with endometriosis.  Reproduction 2009.
42. Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J,
Holcomb K, Rosenwaks Z, Poretsky L: Interactions among Per-
oxisome Proliferator Activated Receptor-{gamma}, Insulin
Signaling Pathways, and Steroidogenic Acute Regulatory
Protein in Human Ovarian Cells.  J Clin Endocrinol Metab 2007,
92(6):2232-2239.
43. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S: Estro-
gen production and metabolism in endometriosis.  Ann N Y
Acad Sci 2002, 955:75-85.
44. Tamaya T, Motoyama T, Ohono Y, Ide N, Tsurusaki T, Okada H:
Steroid receptor levels and histology of endometriosis and
adenomyosis.  Fertil Steril 1979, 31(4):396-400.
45. Janne O, Kauppila A, Kokko E, Lantto T, Ronnberg L, Vihko R: Estro-
gen and progestin receptors in endometriosis lesions: com-
parison with endometrial tissue.  Am J Obstet Gynecol 1981,
141(5):562-566.
46. Lyndrup J, Thorpe S, Glenthoj A, Obel E, Sele V: Altered proges-
terone/estrogen receptor ratios in endometriosis. A com-
parative study of steroid receptors and morphology in
endometriosis and endometrium.  Acta Obstet Gynecol Scand
1987, 66(7):625-629.
47. Bergqvist A, Ferno M: Estrogen and progesterone receptors in
endometriotic tissue and endometrium: comparison accord-
ing to localization and recurrence.  Fertil Steril 1993,
60(1):63-68.
48. Yamashita Y, Asano M, Morishima S, Fujino K, Terai Y, Ohmichi M:
Mitochondrial gene expression in granulosa cells of severe
endometriosis with in vitro fertilization and embryo trans-
fer.  Fertil Steril 2007, 88(6):1703-1705.
49. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K,
Lessey BA, Giudice LC: Expression Profiling of Endometrium
from Women with Endometriosis Reveals Candidate Genes
for Disease-Based Implantation Failure and Infertility.  Endo-
crinology 2003, 144(7):2870-2881.
50. Sherwin JRA, Sharkey AM, Mihalyi A, Simsa P, Catalano RD,
D'Hooghe TM: Global gene analysis of late secretory phase,
eutopic endometrium does not provide the basis for a mini-
mally invasive test of endometriosis.  Hum Reprod 2008,
23(5):1063-1068.